Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Current Diabetes Reports|February 20, 2018
The Landscape of Diabetic Kidney Disease in the United StatesO Kenrik Duru, Tim Middleton, Mona K Tewari, et al.
Journal of Biomolecular Screening|July 5, 2002
Microarray compound screening (microARCS) to identify inhibitors of HIV integraseCaroline A David, Tim Middleton, Debra Montgomery, et al.
Antiviral Research|September 29, 2004
Inhibition of human immunodeficiency virus type I integrase by naphthamidines and 2-aminobenzimidazolesTim Middleton, Hock B Lim, Debra Montgomery, et al.
Antiviral Research|August 18, 2006
Replication efficiency of chimeric replicon containing NS5A-5B genes derived from HCV-infected patient seraRakesh L Tripathi, Preethi Krishnan, Yupeng He, et al.
Analytical Biochemistry|July 24, 2007
Longer wavelength fluorescence resonance energy transfer depsipeptide substrates for hepatitis C virus NS3 proteaseAlex K Konstantinidis, Paul L Richardson, Kevin A Kurtz, et al.
Bioorganic & Medicinal Chemistry Letters|March 5, 2005
Inhibitors of HCV NS5B polymerase: synthesis and structure-activity relationships of N-1-heteroalkyl-4-hydroxyquinolon-3-yl-benzothiadiazinesJohn K Pratt, Pamela Donner, Keith F McDaniel, et al.
Bioorganic & Medicinal Chemistry Letters|December 11, 2007
Synthesis and SAR of novel 1,1-dialkyl-2(1H)-naphthalenones as potent HCV polymerase inhibitorsTodd D Bosse, Daniel P Larson, Rolf Wagner, et al.
Journal of Virological Methods|July 3, 2007
A replicon-based shuttle vector system for assessing the phenotype of HCV NS5B polymerase genes isolated from patient populationsTim Middleton, Yupeng He, Tami Pilot-Matias, et al.
Pageof 2